Dual agonist Surrobody™ simultaneously activates death receptors DR4 and DR5 to induce cancer cell death

Por Milutinovic, Snezana, Kashyap, Arun K., Yanagi, Teruki, Wimer, Carina, Zhou, Sihong, O' Neil, Ryann, Kurtzman, Aaron L., Faynboym, Alexsandr, Xu, Li, Hannum, Charles H., Diaz, Paul W., Matsuzawa, Shu-ichi, Horowitz, Michael, Horowitz, Lawrence, Bhatt, Ramesh R., Reed, John C.
Publicado no Mol Cancer Ther (2015)